BIAFW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (27 Jun 2024 @ 16:00):
No signals from the correlation tool

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment...

Stats
Today's Volume	1 000
Average Volume	0
Market Cap	3.50M
EPS	$-0.200 ( Q1 \| 2024-05-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 39.71
ATR14	$0 (0.00%)

AWH -33.56%

BIAF 2.78%

BIAFW -52.29%

INBS -4.53%

LMDXW 0.00%

PRE -7.09%

PRENW -2.16%

Insider Trading

Date	Person	Action	Amount	type
2023-12-01	Platt Jamie	Buy	0
2023-09-18	Joyce Roby	Buy	0	Common Stock
2021-11-22	Joyce Roby	Buy	14 285	Warrant
2023-09-18	Reveles Xavier Trinidad	Sell	0	Common Stock
2021-08-26	Reveles Xavier Trinidad	Sell	2 142	Stock Option (Right to Buy)

INSIDER POWER
64.50
Last 96 transactions
Buy: 1 799 574 \| Sell: 997 504

Correlation (AI algo v.1.1b): Paired value (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

bioAffinity Technologies, Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

bioAffinity Technologies, Financials

Annual	2023
Revenue:	$2.53M
Gross Profit:	$542 023 (21.40 %)
EPS:	$-0.910

FY	2023
Revenue:	$2.53M
Gross Profit:	$542 023 (21.40 %)
EPS:	$-0.910

FY	2022
Revenue:	$4 803.00
Gross Profit:	$4 336.00 (90.28 %)
EPS:	$-1.810

Financial Reports:

No articles found.

bioAffinity Technologies, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

bioAffinity Technologies,

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.